healthcare AI 3-Model Stack Aims To Reduce Vendor Risk

Healthcare AI firm Altimetrik on Monday opened a healthcare and life sciences center of excellence in Hyderabad, betting regulated drug, payer and care workloads will require multi-model control rather than reliance on a single foundation-model vendor.

Key Takeaways

Altimetrik opened a healthcare and life sciences center of excellence in Hyderabad
The center will focus on product engineering, data modernization and domain workflows for clients across healthcare and life sciences
Altimetrik said clients can use Google Cloud, Gemini Enterprise and ChatGPT Enterprise and switch models without re-architecting the full stack
Altimetrik named PharmaOS as the software layer intended to place workflow logic, governance and integrations above the model layer

Altimetrik said the center will focus on product engineering, data modernization and domain workflows for clients across healthcare and life sciences. An India-focused release gave the same rollout details and named PharmaOS as the firm’s operating layer.

Healthcare AI Needs More Than One Model

The key detail in Altimetrik’s pitch is not the office opening itself but the architecture, and the company said clients can use Google Cloud, Gemini Enterprise and ChatGPT Enterprise, then switch models without re-architecting the full stack.

That matters in healthcare AI because hospitals, drugmakers and insurers rarely want to lock regulated workflows to one vendor’s model roadmap.

A model can improve, get more expensive, change retention terms or lose ground on a specific task. If the application layer is portable, buyers keep more bargaining power.

Altimetrik is positioning that portability as a product, and the release names PharmaOS as the software layer intended to place workflow logic, governance and integrations above the model layer.

That pattern is familiar in enterprise software, but in health care it matters because audit trails, permissions and retention policies are central to compliance and procurement.

Hyderabad Push Follows Enterprise AI Shift

Altimetrik’s move follows a broader change in enterprise AI spending during 2026 as firms moved from pilot chatbots toward domain systems tied to revenue, clinical operations, claims handling and research pipelines.

Also Read: AI Data Center Pipeline Jumps 52 GW In One Month To 456 GW, And The Grid Can’t Keep Up

The company is also betting on Hyderabad as an execution center rather than only a sales beachhead. The city has become a dense market for enterprise software talent, health tech services and global capability centers, supplying a labor pool for both AI product work and regulated process engineering.

Governance And Data Movement

Healthcare AI is not just a model question.

It is a data movement question. Records from labs, insurers, hospital systems and drug trials often sit in separate systems with different rights and retention rules.

The hard part is getting the right data to the right model without leaking it or breaking policy.

Altimetrik’s release emphasizes separation between enterprise systems and model providers, highlighting routing, permissions and the option to change models as pricing or performance shifts. That approach protects buyers from a costly problem, because building directly on one model vendor’s APIs and prompt patterns can force a rewrite of workflows, evaluations and compliance reviews when switching.

Why PharmaOS Matters To Regulated Buyers

PharmaOS matters because Altimetrik is selling a control layer, not only access to models from Google or OpenAI.

A control layer sits between sensitive company data and the language model. It decides which records can move, which users can trigger tasks and how outputs get logged.

Altimetrik’s release says PharmaOS lets firms compare several models inside a single governed workflow and swap engines without rebuilding every connection, a capability targeted at medical affairs teams, payer operations and trial support groups that require long records of what the AI saw and produced.

The next thing to watch is whether Altimetrik discloses real customer deployments, not just the center opening.

Regulated buyers will want proof that model switching works in production and that governance does not slow tasks so much that the AI loses its value.